MedPath

Short-term Outcomes of SILS+1 Versus CLS for Distal Gastric Cancer

Phase 3
Conditions
Surgery
Interventions
Procedure: conventional laparoscopic surgery
Procedure: single-incision plus one-port laparoscopic surgery
Registration Number
NCT05035446
Lead Sponsor
Fujian Cancer Hospital
Brief Summary

To evaluate the short-term outcomes of single-incision plus one-port laparoscopic surgery (SILS + 1) versus conventional laparoscopic surgery(CLS) for distal gastric cancer whose clinical stage was cT1-3N0-2M0

Detailed Description

The gastric cancer patients with cT1-3N0-2M0 were randomized at a 1:1 ratio to the CLS group or the SILS+1group, then it will evaluate the short-term outcomes between two groups.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria
  • pathological diagnosis of gastric cancer
  • clinically diagnosed cT1b-3N0-2M0 lesions according to the 8th Edition of the American Joint Committee on Cancer(AJCC) Cancer Staging Manual(measured using abdominal CT)
  • tumor size ≤ 5cm
  • planned to conduct subtotal gastrectomy
Read More
Exclusion Criteria
  • preoperative radiotherapy and chemotherapy
  • tumor perforation
  • severe mental disease
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
conventional laparoscopic surgery(CLS)conventional laparoscopic surgeryIt requires 5 perforations ports and an auxiliary small incision to perform laparoscopic gastrectomy
single-incision plus one-port laparoscopic surgery(SILS + 1)single-incision plus one-port laparoscopic surgeryIt requires an auxiliary small incision and one more port to perform laparoscopic gastrectomy
Primary Outcome Measures
NameTimeMethod
Rate of complicationsIt is within 30 days after surgery

It means the rate of intraoperative and postoperative complications

Secondary Outcome Measures
NameTimeMethod
pain intensity1-3 days after operation

The investigators use Visual analogue scale(VAS) to evaluate the intensity of pain

Rate of deathIt is within 30 days after surgery

It means the rate of death after operation

Trial Locations

Locations (1)

Fujian Cancer Hospital

🇨🇳

Fuzhou, Fujian, China

© Copyright 2025. All Rights Reserved by MedPath